By: Burrows H.B. No. 1313
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to a study on the side effects, adverse reactions,
  including death, and the effectiveness of vaccines against the
  SARS-CoV-2 virus (COVID-19) or its variants.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  (a) In this section:
               (1)  "Commission" means the Health and Human Services
  Commission.
               (2)  "Executive commissioner" means the executive
  commissioner of the Health and Human Services Commission.
               (3)  "Department" means the Department of State Health
  Services.
               (4)  "COVID 19" means the SARS-CoV-2 virus and any of
  its variants.
               (5)  "Vaccine" means a substance used to stimulate
  immunity to a particular infectious disease or pathogen, typically
  prepared from an inactivated or weakened form of the causative
  agent or from its constituents or products.
         (b)  The Commission in collaboration with the Department
  shall conduct a study to assess the full and complete adverse
  reactions, including death, and effectiveness of each type of
  vaccine used in Texas to defend the human body against "COVID 19.
  The Report must include:
               (1)  The immediate short-term side effects and adverse
  reactions recipients experienced from taking the various Covid-19
  vaccines used in Texas; including but not limited to include:
                     i.  Pain, swelling, or redness where the shot was
  given
                     ii.  Mild fever
                     iii.  Chills
                     iv.  Feeling tired
                     v.  Headache
                     vi.  Muscle and joint aches
               (2)  The immediate serious side effects and adverse
  reactions recipients experienced from taking the various Covid-19
  vaccines used in Texas; including but not limited to include:
                     i.  difficulty breathing;
                     ii.  swelling of the face and throat;
                     iii.  accelerated heartbeat;
                     iv.  a body rash;
                     v.  dizziness; and
                     vi.  weakness
               (3)  Any long-term side effects and adverse reactions
  recipients have experienced from taking the various Covid-19
  vaccines used in Texas; including but not limited to include:
                     i.  paralysis;
                     ii.  Myocarditis;
                     iii.  clotting disorders;
                     iv.  Thrombosis with Thrombocytopenia Syndrome
  (TTS);
                     v.  Guillain-Barré syndrome (GBS);
                     vi.  difficulty thinking or "brain fog,"
                     vii.  chronic pain;
                     viii.  tiredness and fatigue;
                     ix.  loss of taste;
                     x.  depression;
                     xi.  anxiety; and
                     xii.  death.
               (4)  Any misrepresentations about the effectiveness or
  dangers of taking of the vaccine by its manufacturers or any
  governmental agency; and,
               (5)  Any concealment of information about the
  effectiveness or dangers of taking of the vaccine by its
  manufacturers or any governmental agency.
         (c)  The Commission and the Department shall gather
  information for the report from:
               (1)  information collected by the Commission and the
  Department, including information from the department's vital
  statistics unit and the state Medicaid program; and
               (2)  hospitals, treatment centers, available surveys,
               (3)  and other relevant sources.
         SECTION 2.  (a) Not later than January 1, 2024, the
  Commission and Department shall prepare and submit to the Governor,
  Lieutenant Governor, the Speaker of the House of Representatives,
  and the Chairpersons of the relevant Texas legislative committees
  with jurisdiction over the Commission and the Department, a copy of
  the report, summary of any findings, and any recommendations for
  legislative or executive action to reduce the prevalence of
  COVID-19 Vaccine side effects. The department may post the report
  on the department's Internet website.
         (b)  The Commission and Department may accept gifts, grants,
  and donations from any source to fund expenses incurred by the
  Commission and the Department in preparing the report.
         SECTION 3.  This Act expires September 1, 2025.
         SECTION 4.  This Act takes effect immediately if it receives
  a vote of two-thirds of all the members elected to each house, as
  provided by Section 39, Article III, Texas Constitution. If this
  Act does not receive the vote necessary for immediate effect, this
  Act takes effect September 1, 2023.